First Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Buy
1,213
+204
+20% +$208K 0.21% 89
2026
Q1
$928K Buy
1,009
+728
+259% +$738K 0.15% 105
2025
Q4
$302K Sell
281
-236
-46% -$226K 0.05% 205
2025
Q3
$394K Sell
517
-20
-4% -$14.9K 0.07% 172
2025
Q2
$419K Sell
537
-1
-0.2% -$777 0.07% 157
2025
Q1
$444K Sell
538
-6
-1% -$4.99K 0.09% 145
2024
Q4
$420K Sell
544
-3
-0.5% -$2.48K 0.08% 153
2024
Q3
$485K Buy
547
+1
+0.2% +$899 0.09% 133
2024
Q2
$494K Hold
546
0.1% 125
2024
Q1
$425K Buy
+546
New +$389K 0.09% 137
2022
Q3
Sell
-60
Closed -$19K 354
2022
Q2
$19K Sell
60
-26
-30% -$7.8K 0.01% 316
2022
Q1
$25K Sell
86
-5
-5% -$1.29K 0.01% 308
2021
Q4
$25K Buy
91
+11
+14% +$2.79K 0.01% 310
2021
Q3
$18K Hold
80
0.01% 318
2021
Q2
$18K Hold
80
0.01% 315
2021
Q1
$15K Hold
80
0.01% 324
2020
Q4
$14K Hold
80
0.01% 314
2020
Q3
$12K Hold
80
0.01% 304
2020
Q2
$13K Sell
80
-80
-50% -$12.3K 0.01% 295
2020
Q1
$22K Buy
+160
New +$22K 0.02% 279

Other funds holding LLY

First Bank & Trust's LLY Position: Q2 2026 in Review

First Bank & Trust increased its Eli Lilly (LLY) stake by 20% in Q2 2026, buying an estimated $208K and bringing the position to 1,213 shares worth $1.45M. The position accounts for 0.21% of the portfolio, ranked #89.

First Bank & Trust first reported a position in LLY in Q1 2020 and has held it in 20 quarters since. 1,761 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • First Bank & Trust held 1,213 shares of Eli Lilly worth $1.45M as of Q2 2026.
  • First Bank & Trust bought 204 Eli Lilly shares in Q2 2026, an estimated $208K.
  • Eli Lilly made up 0.21% of First Bank & Trust's portfolio in Q2 2026, its #89 holding.
  • First Bank & Trust first reported a position in Eli Lilly in Q1 2020 and has held it in 20 quarters since.
  • 1,761 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.